跳至主要内容
临床试验/CTRI/2021/10/037322
CTRI/2021/10/037322已完成Unknown

PMOS to evaluate the safety and efficacy of gentle baby soap in 0-36 months babies.

Himalaya Wellness Company25 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年1月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
500
试验地点
25
主要终点
To evaluate the safety and efficacy of Test Product in study population

研究概览

简要总结

Study Objective: Toevaluate the safety and efficacy of gentle baby soap in 0-36 months babies

Study Design: Anopen label, post marketing observational study.

Study Methodology:

  1. Parents/LegallyAcceptable Representatives (LARs) of the baby will be provided with theinformed consent document and explained about the study in detail.

  2. Babies whofulfil the selection criteria will be enrolled into the study after writteninformed consent.

  3. The subject’sparent /LAR will be provided with The Himalaya gentle baby soap, and they willbe instructed on the use the product by the study doctor/ coordinator.

  4. Assessments willbe performed on Day 1/baseline and at the end of the study visit (Day 15) asper the schedule of events.

  5. If subjectsscore for Local intolerance is scored 1= Mild, 2=Moderate, 3=Severe, then theundesirable effect page to be completed.

  6. All undesirableeffects to be followed up till the event is stabilized or 7days whichever isearlier

Study duration: Thisstudy is planned for 15 days. The subjects must use the test product for all 14days.

Number of Subjects:500 subjects will be enrolled.

Study Site: The studywill be conducted at Approximately 25 sites.

Directions to Use: Wet the baby’s body andface with water, apply the soap generously, work up lather and rinse withwater.

研究设计

研究类型
Observational

入排标准

年龄范围
0.00 Day(s) 至 36.00 Month(s)(—)
性别
All

入选标准

  • •Subjects in the age group of 0 to 36 months (inclusive of both genders)
  • •Subjects in general good health as determined from a recent medical history and physical examination
  • •Subjects mother/legal representative, preferably mother willing to give a voluntary written informed consent and agree to comply with the study protocol.

排除标准

  • •A known history or present allergic condition that may require medical attention
  • •Chronic illness which may influence the cutaneous assessment
  • •Subjects not willing to stop the use of other soaps during study period.

结局指标

主要结局

To evaluate the safety and efficacy of Test Product in study population

时间窗: Study duration: This study is planned for 15 days

次要结局

  • Not Applicable(Not Applicable)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (25)

Loading locations...

相似试验